When and how to use serum tumor markers in clinical practice.
作者信息
Markman M
机构信息
Department of Hematology/Medical Oncology, Cleveland Clinic Foundation, Oh 44195, USA.
出版信息
Cleve Clin J Med. 1997 Jan;64(1):27-9. doi: 10.3949/ccjm.64.1.27.
PMID:9014381
Abstract
摘要
相似文献
1
When and how to use serum tumor markers in clinical practice.血清肿瘤标志物在临床实践中的使用时机及方法。
Cleve Clin J Med. 1997 Jan;64(1):27-9. doi: 10.3949/ccjm.64.1.27.
2
Serum tumor markers: past, state of the art, and future.血清肿瘤标志物：过去、现状与未来。
Int J Biol Markers. 2001 Apr-Jun;16(2):73-86.
3
Circulating tumor markers: a guide to their appropriate clinical use | Comparative summary of recommendations from clinical practice guidelines (PART 2).循环肿瘤标志物：其合理临床应用指南 | 临床实践指南推荐意见的比较总结（第2部分）
Int J Biol Markers. 2017 Mar 2;32(1):e1-e52. doi: 10.5301/ijbm.5000259.
4
Circulating tumor markers: a guide to their appropriate clinical use | Comparative summary of recommendations from clinical practice guidelines (PART 3).循环肿瘤标志物：其合理临床应用指南 | 临床实践指南推荐意见的比较总结（第3部分）
Int J Biol Markers. 2017 May 4;32(2):e147-e181. doi: 10.5301/ijbm.5000272.
5
Search for serum tumor markers continues.对血清肿瘤标志物的搜寻仍在继续。
J Natl Cancer Inst. 1992 Mar 18;84(6):387-9. doi: 10.1093/jnci/84.6.387.
6
The use and potential of serum tumour markers, new and old.血清肿瘤标志物的应用与潜力，新的与旧的。
Drugs. 1989 Jul;38(1):9-18. doi: 10.2165/00003495-198938010-00002.
7
Diagnostic role of tumor markers.肿瘤标志物的诊断作用。
Med Clin (Barc). 2019 Mar 1;152(5):185-187. doi: 10.1016/j.medcli.2018.10.011. Epub 2018 Nov 27.
8
[Serum tumour markers in asymptomatic patients].[无症状患者的血清肿瘤标志物]
Med Clin (Barc). 2015 Oct 5;145(7):319-20. doi: 10.1016/j.medcli.2015.03.008. Epub 2015 May 13.
9
Mesothelin in serum.
Biochem Biophys Res Commun. 2008 Nov 21;376(3):629; author reply 630. doi: 10.1016/j.bbrc.2008.08.080. Epub 2008 Sep 27.
10
Autoantibody biomarkers in the detection of cancer.用于癌症检测的自身抗体生物标志物。
Biochim Biophys Acta. 2006 Jun;1762(6):587-91. doi: 10.1016/j.bbadis.2006.04.001. Epub 2006 Apr 19.
Zotero 插件